News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,501 Results
Type
Article (43050)
Company Profile (308)
Press Release (661143)
Section
Business (208086)
Career Advice (2080)
Deals (35929)
Drug Delivery (90)
Drug Development (82179)
Employer Resources (170)
FDA (16697)
Job Trends (15116)
News (351865)
Policy (33419)
Tag
Academia (2694)
Alliances (50737)
Alzheimer's disease (1253)
Approvals (16613)
Artificial intelligence (126)
Bankruptcy (354)
Best Places to Work (11729)
Biotechnology (221)
Breast cancer (111)
Cancer (970)
Career advice (1732)
Cell therapy (218)
Clinical research (64908)
Collaboration (344)
Compensation (172)
COVID-19 (2602)
C-suite (85)
Data (913)
Diabetes (141)
Diagnostics (6263)
Drug pricing (84)
Earnings (85254)
Employer resources (148)
Events (111685)
Executive appointments (260)
FDA (17160)
Funding (305)
Gene therapy (159)
GLP-1 (576)
Government (4469)
Healthcare (19298)
Infectious disease (2681)
Inflammatory bowel disease (103)
Interviews (320)
IPO (16438)
Job creations (3692)
Job search strategy (1481)
Layoffs (413)
Legal (8034)
Lung cancer (161)
Manufacturing (160)
Medical device (13718)
Medtech (13723)
Mergers & acquisitions (19523)
Metabolic disorders (377)
Neuroscience (1506)
NextGen Class of 2024 (6766)
Non-profit (4598)
Northern California (1269)
Obesity (224)
Opinion (184)
Patents (97)
People (57294)
Phase I (20207)
Phase II (28579)
Phase III (21296)
Pipeline (256)
Postmarket research (2596)
Preclinical (8668)
Radiopharmaceuticals (237)
Rare diseases (189)
Real estate (6034)
Regulatory (22145)
Research institute (2436)
Resumes & cover letters (366)
Southern California (1142)
Startups (3678)
United States (12256)
Vaccines (567)
Weight loss (166)
Date
Today (212)
Last 7 days (930)
Last 30 days (3211)
Last 365 days (36253)
2024 (31433)
2023 (40806)
2022 (51978)
2021 (56632)
2020 (55203)
2019 (47982)
2018 (36148)
2017 (33123)
2016 (32602)
2015 (38725)
2014 (32437)
2013 (27611)
2012 (29799)
2011 (30434)
2010 (28426)
Location
Africa (757)
Arizona (190)
Asia (38665)
Australia (6307)
California (2889)
Canada (1196)
China (218)
Colorado (128)
Connecticut (134)
Europe (84011)
Florida (409)
Georgia (106)
Illinois (320)
Indiana (185)
Kansas (97)
Maryland (546)
Massachusetts (2372)
Michigan (144)
Minnesota (262)
New Jersey (861)
New York (873)
North Carolina (690)
Northern California (1269)
Ohio (131)
Pennsylvania (776)
South America (1142)
Southern California (1142)
Texas (404)
Utah (83)
Washington State (338)
704,501 Results for "delcath systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company’s Board of Directors effective May 23, 2024.
May 28, 2024
·
4 min read
Business
Delcath Systems Reports First Quarter 2024 Results and Business Highlights
Delcath Systems, Inc. today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 14, 2024
·
9 min read
Press Releases
Delcath Systems to Participate in Upcoming November 2024 Investor Conferences
November 4, 2024
·
2 min read
Business
Delcath Systems to Host First Quarter 2024 Earnings Call
Delcath Systems, Inc. announced it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2024.
May 7, 2024
·
2 min read
Business
Delcath Systems to Host Third Quarter 2024 Earnings Call
October 25, 2024
·
2 min read
Deals
Delcath Systems Closes $7 Million Private Placement
Delcath Systems, Inc. confirmed the closing of the previously announced private placement with certain accredited investors comprised of existing investors.
March 20, 2024
·
5 min read
Business
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
October 17, 2024
·
5 min read
Business
Delcath Systems Appoints Martha S. Rook as Chief Operating Officer
Delcath Systems, Inc. is pleased to announce the appointment of Martha S. Rook as its new Chief Operating Officer.
March 18, 2024
·
3 min read
Pharm Country
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
Delcath Systems, Inc. announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as a material inducement to the employment of two individuals whose employment commenced in April 2024.
May 3, 2024
·
2 min read
Business
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Delcath Systems, Inc. (Nasdaq: DCTH) (“Delcath” or the “Company”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported recent business highlights and financial results for the fourth quarter and full year ended December 31, 2023.
March 26, 2024
·
9 min read
1 of 70,451
Next
